Back

Hot Pursuit

Wanbury surged 8.91% to Rs 261.70 after the company announced that its Andhra Pradesh-based Tanuku facility had successfully completed an inspection by the Brazilian Health Regulatory Agency (ANVISA), with zero observations.

Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations

12-May-2025, 03:25
The inspection was conducted from 16 December to 20 December 2024, confirmed the facility's strict adherence to Current Good Manufacturing Practices (cGMP).

As a result, ANVISA has granted the facility the Good Manufacturing Practices (GMP) Certificate.

Wanbury is a pharmaceutical company with a presence in the global API market and domestic branded formulations.

The company's consolidated net profit declined 88.12% to Rs 1.22 crore as revenues fell by 8.28% to Rs 133.45 crore in Q3 FY25 as compared with Q3 FY24.